[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Citations 0
From the Centers for Disease Control and Prevention
September 19, 2001

Update on Spectinomycin Availability in the United States

JAMA. 2001;286(11):1308-1309. doi:10.1001/jama.286.11.1308-JWR0919-3-1

MMWR. 2001;50:646

In April 2001, Pharmacia Corporation (Peapack, New Jersey) announced the discontinuation of its U.S. production of spectinomycin (Trobicin®)* and that its remaining inventory would expire on June 30, 2001.1 Since then, examination of the inventory has revealed that, although some lots of the bacteriostatic water packaged with the spectinomycin have expired, the spectinomycin powder has a shelf-life beyond June 30. The Food and Drug Administration has approved Pharmacia's request to remove the bacteriostatic water and to relabel the current inventory of spectinomycin to expire on December 31. To obtain spectinomycin or to verify whether a spectinomycin lot may continue to be used, contact Wendy Johnson, Pharmacia Corporation, telephone (800) 976-7741, extension 30110; fax (800) 852-6421.

Pharmacia is planning to resume U.S. spectinomycin production later in 2001. When new spectinomycin is available, it will be distributed again through the usual wholesale distribution network.

*Use of trade names is for identification only and does not imply endorsement by CDC or the U.S. Department of Health and Human Services.
†All MMWR references are available on the Internet at http://www.cdc.gov/mmwr. Use the search function to find specific articles.
CDC, Shortage of spectinomycin—United States. MMWR. 2001;50470